SURAMIN

被引：44

作者：

EISENBERGER, MA

REYNO, LM

机构：

[1] JOHNS HOPKINS UNIV,DEPT UROL,BALTIMORE,MD 21218

[2] HAMILTON REG CANC CTR,HAMILTON,ON,CANADA

来源：

CANCER TREATMENT REVIEWS | 1994年 / 20卷 / 03期

关键词：

D O I：

10.1016/0305-7372(94)90003-5

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：259 / 273

页数：15

共 27 条

[1] SURAMIN, AN EXPERIMENTAL CHEMOTHERAPEUTIC DRUG, ACTIVATES THE RECEPTOR FOR EPIDERMAL GROWTH-FACTOR AND PROMOTES GROWTH OF CERTAIN MALIGNANT-CELLS [J].

CARDINALI, M ;

SARTOR, O ;

ROBBINS, KC .

JOURNAL OF CLINICAL INVESTIGATION, 1992, 89 (04) :1242-1247

[2] SURAMIN THERAPY IN AIDS AND RELATED DISORDERS - REPORT OF THE UNITED-STATES-SURAMIN-WORKING-GROUP [J].

CHESON, BD ;

LEVINE, AM ;

MILDVAN, D ;

KAPLAN, LD ;

WOLFE, P ;

RIOS, A ;

GROOPMAN, JE ;

GILL, P ;

VOLBERDING, PA ;

POIESZ, BJ ;

GOTTLIEB, MS ;

HOLDEN, H ;

VOLSKY, DJ ;

SILVER, SS ;

HAWKINS, MJ .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1987, 258 (10) :1347-1351

[3]

CONSTANTOPOULOS G, 1983, AM J PATHOL, V113, P266

[4] SURAMIN - POTENT INHIBITOR OF THE REVERSE-TRANSCRIPTASE OF RNA TUMOR-VIRUSES [J].

DECLERCQ, E .

CANCER LETTERS, 1979, 8 (01) :9-22

[5] RESPONSE TO FLUTAMIDE WITHDRAWAL IN ADVANCED PROSTATE-CANCER IN PROGRESSION UNDER COMBINATION THERAPY [J].

DUPONT, A ;

GOMEZ, JL ;

CUSAN, L ;

KOUTSILIERIS, M ;

LABRIE, F .

JOURNAL OF UROLOGY, 1993, 150 (03) :908-913

[6]

EISENBERGER M, 1993, P AM SOC CLIN ONCOL, V12, P247

[7] SURAMIN, AN ACTIVE-DRUG FOR PROSTATE-CANCER - INTERIM OBSERVATIONS IN A PHASE-I TRIAL [J].

EISENBERGER, MA ;

REYNO, LM ;

JODRELL, DI ;

SINIBALDI, VJ ;

TKACZUK, KH ;

SRIDHARA, R ;

ZUHOWSKI, EG ;

LOWITT, MH ;

JACOBS, SC ;

EGORIN, MJ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (08) :611-621

[8] INHIBITORY EFFECT OF SURAMIN ON RECEPTOR-BINDING AND CYTOTOXIC ACTIVITY OF TUMOR-NECROSIS-FACTOR-ALPHA [J].

GRAZIOLI, L ;

ALZANI, R ;

CIOMEI, M ;

MARIANI, M ;

RESTIVO, A ;

COZZI, E ;

MARCUCCI, F .

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1992, 14 (04) :637-642

[9]

GREGORY LC, 1992, CLIN CHEM, V38, P2557

[10]

Hawking F, 1978, Adv Pharmacol Chemother, V15, P289, DOI 10.1016/S1054-3589(08)60486-X

← 1 2 3 →